[EN] 2-ADAMANTANEMETHANAMINE COMPOUNDS FOR TREATING ABNORMALITIES IN GLUTAMATERGIC TRANSMISSION<br/>[FR] COMPOSES DE 2-ADAMANTANEMETHANAMINE DESTINES AU TRAITEMENT D'ANOMALIES DE LA TRANSMISSION GLUTAMATERGIQUE
                        
                            
                                申请人:VERNALIS RESEARCH LIMITED
                            
                            
                                公开号:WO2000044371A1
                            
                            
                                公开(公告)日:2000-08-03
                            
                            The use of a compound of formula (1), wherein R1, R2, R3, R4, R5 and R6 are independently selected from hydrogen, alkyl and aryl, or pharmaceutically acceptable salts thereof, with the proviso that wherein R1 to R4 and R6 are hydrogen, R5 is not selected from CH2CH2NHSO2CH3, CH2CH2NHSO2CF3 and methyl substituted by SO2NH2, SO3H, PO3H2, CONHOH or a heterocyclic group selected from formulae (a), (b), (c), (d) and (e) in the manufacture of a medicament for use in the treatment of a condition generally associated with abnormalities in glutamatergic transmission.